156 related articles for article (PubMed ID: 36730788)
1. Novelties from the Joint EANM/SNMMI/ANZSNM Guidelines on Immunotherapy.
Lopci E; Castello A; Filippi L
Cancer Biother Radiopharm; 2023 May; 38(4):211-215. PubMed ID: 36730788
[TBL] [Abstract][Full Text] [Related]
2. Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [
Lopci E; Hicks RJ; Dimitrakopoulou-Strauss A; Dercle L; Iravani A; Seban RD; Sachpekidis C; Humbert O; Gheysens O; Glaudemans AWJM; Weber W; Wahl RL; Scott AM; Pandit-Taskar N; Aide N
Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2323-2341. PubMed ID: 35376991
[TBL] [Abstract][Full Text] [Related]
3. Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [
Lopci E; Aide N; Dimitrakopoulou-Strauss A; Dercle L; Iravani A; Seban RD; Sachpekidis C; Humbert O; Gheysens O; Glaudemans AWJM; Weber WA; Van den Abbeele AD; Wahl RL; Scott AM; Pandit-Taskar N; Hicks RJ
Cancer Imaging; 2022 Dec; 22(1):73. PubMed ID: 36539908
[TBL] [Abstract][Full Text] [Related]
4. SNMMI Procedure Standard/EANM Practice Guideline on Pediatric
Vali R; Alessio A; Balza R; Borgwardt L; Bar-Sever Z; Czachowski M; Jehanno N; Kurch L; Pandit-Taskar N; Parisi M; Piccardo A; Seghers V; Shulkin BL; Zucchetta P; Lim R
J Nucl Med; 2021 Jan; 62(1):99-110. PubMed ID: 33334912
[TBL] [Abstract][Full Text] [Related]
5. FDG PET/CT for assessing tumour response to immunotherapy : Report on the EANM symposium on immune modulation and recent review of the literature.
Aide N; Hicks RJ; Le Tourneau C; Lheureux S; Fanti S; Lopci E
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):238-250. PubMed ID: 30291373
[TBL] [Abstract][Full Text] [Related]
6. EANM guideline on the role of 2-[
Delgado Bolton RC; Aide N; Colletti PM; Ferrero A; Paez D; Skanjeti A; Giammarile F
Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3286-3302. PubMed ID: 34215923
[TBL] [Abstract][Full Text] [Related]
7. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0.
Boellaard R; O'Doherty MJ; Weber WA; Mottaghy FM; Lonsdale MN; Stroobants SG; Oyen WJ; Kotzerke J; Hoekstra OS; Pruim J; Marsden PK; Tatsch K; Hoekstra CJ; Visser EP; Arends B; Verzijlbergen FJ; Zijlstra JM; Comans EF; Lammertsma AA; Paans AM; Willemsen AT; Beyer T; Bockisch A; Schaefer-Prokop C; Delbeke D; Baum RP; Chiti A; Krause BJ
Eur J Nucl Med Mol Imaging; 2010 Jan; 37(1):181-200. PubMed ID: 19915839
[TBL] [Abstract][Full Text] [Related]
8. Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [
Law I; Albert NL; Arbizu J; Boellaard R; Drzezga A; Galldiks N; la Fougère C; Langen KJ; Lopci E; Lowe V; McConathy J; Quick HH; Sattler B; Schuster DM; Tonn JC; Weller M
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):540-557. PubMed ID: 30519867
[TBL] [Abstract][Full Text] [Related]
9. EANM/SNMMI guideline for 18F-FDG use in inflammation and infection.
Jamar F; Buscombe J; Chiti A; Christian PE; Delbeke D; Donohoe KJ; Israel O; Martin-Comin J; Signore A
J Nucl Med; 2013 Apr; 54(4):647-58. PubMed ID: 23359660
[No Abstract] [Full Text] [Related]
10. Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [
Piccardo A; Albert NL; Borgwardt L; Fahey FH; Hargrave D; Galldiks N; Jehanno N; Kurch L; Law I; Lim R; Lopci E; Marner L; Morana G; Young Poussaint T; Seghers VJ; Shulkin BL; Warren KE; Traub-Weidinger T; Zucchetta P
Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3852-3869. PubMed ID: 35536420
[TBL] [Abstract][Full Text] [Related]
11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
12. Interpretation of 2-[
Manson G; Lemchukwu AC; Mokrane FZ; Lopci E; Aide N; Vercellino L; Houot R; Dercle L
Eur Radiol; 2022 Sep; 32(9):6536-6544. PubMed ID: 35344061
[TBL] [Abstract][Full Text] [Related]
13. Guidelines for the use of 18F-FDG in infection and inflammation: a new step in cooperation between the EANM and SNMMI.
Buscombe J
Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):1120-1. PubMed ID: 23568088
[No Abstract] [Full Text] [Related]
14. Use of Fluoro-[18F]-Deoxy-2-D-Glucose Positron Emission Tomography/Computed Tomography to Predict Immunotherapy Treatment Response in Patients With Squamous Cell Oral Cavity Cancers.
Shah H; Wang Y; Cheng SC; Gunasti L; Chen YH; Lako A; Guenette J; Rodig S; Jo VY; Uppaluri R; Haddad R; Schoenfeld JD; Jacene HA
JAMA Otolaryngol Head Neck Surg; 2022 Mar; 148(3):268-276. PubMed ID: 35050348
[TBL] [Abstract][Full Text] [Related]
15. Evidence-based guideline of the European Association of Nuclear Medicine (EANM) on imaging infection in vascular grafts.
Lauri C; Signore A; Glaudemans AWJM; Treglia G; Gheysens O; Slart RHJA; Iezzi R; Prakken NHJ; Debus ES; Honig S; Lejay A; Chakfé N
Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3430-3451. PubMed ID: 35376992
[TBL] [Abstract][Full Text] [Related]
16. Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[
Vaz SC; Adam JA; Delgado Bolton RC; Vera P; van Elmpt W; Herrmann K; Hicks RJ; Lievens Y; Santos A; Schöder H; Dubray B; Visvikis D; Troost EGC; de Geus-Oei LF
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1386-1406. PubMed ID: 35022844
[TBL] [Abstract][Full Text] [Related]
17. The value of FDG PET/CT imaging in outcome prediction and response assessment of lymphoma patients treated with immunotherapy: a meta-analysis and systematic review.
Kiamanesh Z; Ayati N; Sadeghi R; Hawkes E; Lee ST; Scott AM
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4661-4676. PubMed ID: 35932329
[TBL] [Abstract][Full Text] [Related]
18. Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[
Vaz SC; Adam JA; Delgado Bolton RC; Vera P; van Elmpt W; Herrmann K; Hicks RJ; Lievens Y; Santos A; Schöder H; Dubray B; Visvikis D; Troost EGC; de Geus-Oei LF
Radiother Oncol; 2022 Mar; 168():37-39. PubMed ID: 35066001
[TBL] [Abstract][Full Text] [Related]
19. Cancer immunotherapy is accompanied by distinct metabolic patterns in primary and secondary lymphoid organs observed by non-invasive
Schwenck J; Schörg B; Fiz F; Sonanini D; Forschner A; Eigentler T; Weide B; Martella M; Gonzalez-Menendez I; Campi C; Sambuceti G; Seith F; Quintanilla-Martinez L; Garbe C; Pfannenberg C; Röcken M; la Fougere C; Pichler BJ; Kneilling M
Theranostics; 2020; 10(2):925-937. PubMed ID: 31903160
[No Abstract] [Full Text] [Related]
20. Current Status of Molecular Imaging in Infections.
Sollini M; Lauri C; Boni R; Lazzeri E; Erba PA; Signore A
Curr Pharm Des; 2018; 24(7):754-771. PubMed ID: 29318965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
